Electronic State Business Daily Search


Sign in is NOT required.
For instructions on submitting bid responses, please review the posting entity’s solicitation and attached bid documents.


IFB for Clozapine Point-of-Care Testing

Solicitation ID: R2270-2021-1

Status: Closed

Contact Name: Brody Ballard

Contact Number: 512-440-4022

Contact Email: Brody.Ballard@Integralcare.org

Response Due Date: 2/19/2021

Response Due Time: 4:00 PM

Agency/Texas SmartBuy Member Number: R2270

Days Solicited: 21+ Days for Solicitation Notice

Solicitation Posting Date: 1/20/2021

Last Modified: 2/19/2021 4:01 pm

Solicitation Description:

Integral Care is seeking bids to provide Clozapine Point-of-Care Testing equipment and a software package. Point-of-Care Testing equipment must allow for absolute neutrophil count (ANC) lab testing to occur in a variety of settings, including the clinic or client’s home, using a finger-prick and test strip. Results must be available within 10 minutes, to allow for real-time treatment response. The equipment should be capable of being operated by Integral Care trained personnel, including nurses, medical assistants, or other designed staff. The equipment would preferably have interoperability capability with federal Risk Evaluation and Mitigation Strategy (REMS) program, with results simultaneously transmitted to the clozapine monitoring registry, the prescriber and the pharmacy. 


Class/Item Code: 19314-Blood Chemistry Reagents And Tests, Nonautomated (For Bun, Enzymes, Glucose, Proteins, Triglycerides, Etc.)

Attachments

#NameDescription
1ESBD_File_225075_IFB - Clozapine testing (1-20-21).docIntegral Care is seeking bids to provide Clozapine Point-of-Care Testing equipment and a software package. Point-of-Care Testing equipment must allow for absolute neutrophil count (ANC) lab testing to occur in a variety of settings, including the clinic or client’s home, using a finger-prick and test strip. Results must be available within 10 minutes.